U.S. market Open. Closes in 3 hours 30 minutes

CNCR | Loncar Cancer Immunotherapy ETF Holdings

(Stock Exchange: NASDAQ)
Symbol Name Market Cap Weight Valuation Profitability Growth Health 200SMA Price Change IV IV Rank
TIL Instil Bio, Inc. 417.46M 3.59%
64.19 -2.90% 576.12% 75.97%
REPL Replimune Group, Inc. 766.57M 3.54%
11.22 1.26% 74.66% 17.82%
IOVA Iovance Biotherapeutics, Inc. 3.17B 3.47%
10.44 2.65% 74.67% 9.54%
ZYME Zymeworks Inc. 908.70M 3.45%
12.79 2.16% 107.83% 32.52%
ARGX argenx SE 32.03B 3.42%
535.67 1.25% 27.93% 5.11%
GMAB Genmab A/S 16.82B 3.42%
26.49 1.11% 82.71% 40.59%
AZN AstraZeneca PLC 245.88B 3.39%
79.30 0.92% 22.04% 41.59%
BMY Bristol-Myers Squibb Company 99.88B 3.39%
49.27 -0.95% 31.12% 70.51%
CRSP CRISPR Therapeutics AG 4.30B 3.39%
50.49 1.81% 56.34% 13.85%
MRK Merck & Co., Inc. 296.32B 3.37%
116.90 -1.47% 21.19% 30.70%
NKTR Nektar Therapeutics 235.66M 3.37%
1.2802 1.60% 612.53% 9.10%
XNCR Xencor, Inc. 1.50B 3.37%
21.42 2.73% 73.08% 55.14%
REGN Regeneron Pharmaceuticals, Inc. 125.79B 3.36%
1,160.24 1.88% 25.78% 44.23%
FATE Fate Therapeutics, Inc. 461.78M 3.33%
4.06 4.49% 135.03% 5.79%
GILD Gilead Sciences, Inc. 105.05B 3.33%
84.38 0.58% 22.75% 21.24%
RCUS Arcus Biosciences, Inc. 1.56B 3.32%
17.11 3.76% 111.32% 60.76%
ATRA Atara Biotherapeutics, Inc. 47.01M 3.30%
8.29 5.29% 769.79% 94.72%
ALLO Allogene Therapeutics, Inc. 624.20M 3.29%
2.9850 3.65% 176.39% 46.90%
RUBY Rubius Therapeutics, Inc. 3.29%
TRIL Trillium Therapeutics Inc. 3.29%
BLUE bluebird bio, Inc. 97.33M 3.28%
0.5019 1.39% 236.87% 83.03%
IBRX ImmunityBio, Inc. 2.47B 3.28%
3.54 3.56% 70.29% 8.16%
IMAB I-Mab 86.95M 3.25%
1.1289 3.57% 450.31% 58.29%
IGMS IGM Biosciences, Inc. 1.05B 3.23%
17.67 6.13% 99.28% 29.65%
STTK Shattuck Labs, Inc. 181.27M 3.23%
3.80 4.05% 447.77% 78.77%
ALXO ALX Oncology Holdings Inc. 116.14M 3.21%
2.2050 3.03% 204.07% 27.11%
LEGN Legend Biotech Corporation 9.26B 3.20%
50.54 1.26% 61.16% 52.07%
BGNE BeiGene, Ltd. 22.27B 3.19%
200.65 1.71% 33.80% 15.54%
MGNX MacroGenics, Inc. 213.26M 3.17%
3.40 3.02% 74.78% 9.73%
YMAB Y-mAbs Therapeutics, Inc. 641.36M 3.12%
14.39 6.04% 71.19% 23.27%
Cash&Other 0.13%
Total holdings: 31 Recognized Stocks: 28 Others: 3
An error has occurred. This application may no longer respond until reloaded. Reload 🗙